Woodline Partners LP

Position in GPCR — Structure Therapeutics Inc.

CIK 1784547 San Francisco, CA

Position in GPCR

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$9,196,945

+$579,561 QoQ

Shares Held

190,808

+54.0% QoQ

Ownership

0.089%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

Woodline Partners LP holds $3,424,016,489 across 189 Biotechnology names. GPCR ranks #87 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc.	2,506,570	$243,763,932
2	TNGX	Tango Therapeutics, Inc.	8,000,013	$167,360,271
3	PTGX	Protagonist Therapeutics, Inc	1,414,173	$149,053,834
4	QNCX	Quince Therapeutics, Inc.	5,200,000	$105,040,000
5	RCUS	Arcus Biosciences, Inc.	3,777,798	$81,600,436
6	ALNY	Alnylam Pharmaceuticals, Inc.	243,883	$80,693,568
7	SRRK	Scholar Rock Holding Corp	1,500,470	$73,763,105
8	RYTM	Rhythm Pharmaceuticals, Inc.	758,891	$66,000,750

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$9,196,945	190,808	+54.0%	Shares	Sole	2026-05-15
2025-12-31	$8,617,384	123,902	+89.3%	Shares	Sole	2026-02-17
2025-09-30	$1,832,320	65,440	-62.9%	Shares	Sole	2025-11-14
2025-06-30	$3,659,635	176,453	+0.6%	Shares	Sole	2025-08-14
2025-03-31	$3,036,589	175,424	-47.5%	Shares	Sole	2025-05-15
2024-12-31	$9,055,395	333,901	+0.7%	Shares	Sole	2025-02-14
2024-09-30	$14,552,738	331,573	-1.7%	Shares	Sole	2024-11-14
2024-06-30	$13,249,737	337,401	+87.6%	Shares	Sole	2024-08-14
2024-03-31	$7,710,171	179,892	+0.4%	Shares	Sole	2024-05-15
2023-12-31	$7,304,966	179,219	+5.4%	Shares	Sole	2024-02-14
2023-09-30	$8,571,400	170,000	0.0%	Shares	Sole	2023-11-14
2023-06-30	$7,066,900	170,000	0.0%	Shares	Sole	2023-08-14
2023-03-31	$4,044,300	170,000	—	Shares	Sole	2023-05-15
No filing history on record for this holder in this stock.